Latest filing published 16 Sept 2015 for IMMUNE PHARMACEUTICALS INC, €65k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Rene Pierre Azria: trading record in brief
Rene Pierre Azria is a declared insider at 2 companies; the most frequent names are Jarden Corp and Immune Pharmaceuticals Inc. We count 20 filings; the first trade dates from 22 November 2006 and the latest from 14 September 2015.
In open-market terms, that means 8 purchases worth €162k on one side and 1 sale worth €26k on the other. Taken together, the purchases exceed the sales by €136k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 8 share grants and 1 option exercise. So far in 2015, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €15k.
The latest filing, published on 16 September 2015, reports an open-market purchase of €65k in Immune Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rene Pierre Azria
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$1.48Common StockSEC:0001144204-15-055301:0Canonical exit: 13 Dec 2015 (T+90)
- 20,243 shares@ US$36.00Common StockSEC:0001140361-12-014572:0
- 29,000 shares@ US$10.65Common StockSEC:0001140361-12-013145:0
- 8,757 shares@ US$35.27Common StockSEC:0001140361-12-013145:1
- 3,500 shares0COMMON STOCKSEC:0001140361-11-033390:0
- 1,000 shares@ US$35.40COMMON STOCKSEC:0001140361-11-012225:0
- 3,500 shares0COMMON STOCKSEC:0001140361-10-030135:0
- 3,500 shares0Common StockSEC:0001005477-09-002668:0
- 600 shares@ US$18.00Common StockSEC:0001005477-08-004089:0Canonical exit: 4 Sept 2008 (T+90)
- 1,400 shares@ US$18.00Common StockSEC:0001005477-08-004089:1Canonical exit: 7 Sept 2008 (T+90)
- 2,000 shares@ US$18.00Common StockSEC:0001005477-08-004048:0Canonical exit: 7 Sept 2008 (T+90)
- 4,000 shares0Common StockSEC:0001005477-08-003171:0
- 1,000 shares@ US$20.00Common StockSEC:0001005477-08-000227:0Canonical exit: 8 Apr 2008 (T+90)
- 700 shares@ US$26.00Common StockSEC:0001005477-07-009974:0Canonical exit: 25 Feb 2008 (T+90)
- 1,000 shares@ US$29.26Common StockSEC:0001005477-07-004950:0
- 300 shares@ US$33.79Common StockSEC:0001005477-07-004342:0Canonical exit: 5 Nov 2007 (T+90)
- 700 shares@ US$33.80Common StockSEC:0001005477-07-004342:1Canonical exit: 5 Nov 2007 (T+90)
- 3,500 shares0Common StockSEC:0001005477-07-003247:0
- 500 shares0Common StockSEC:0001005477-06-005747:0
- 3,250 shares0Common StockSEC:0001005477-06-005631:0
20 of 20 declarations
